Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 135

1.

Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania.

Romore I, Njau RJ, Semali I, Mwisongo A, Ba Nguz A, Mshinda H, Tanner M, Abdulla S.

Malar J. 2016 Mar 8;15:143. doi: 10.1186/s12936-016-1197-6.

2.

Effectiveness of a Home-Based Counselling Strategy on Neonatal Care and Survival: A Cluster-Randomised Trial in Six Districts of Rural Southern Tanzania.

Hanson C, Manzi F, Mkumbo E, Shirima K, Penfold S, Hill Z, Shamba D, Jaribu J, Hamisi Y, Soremekun S, Cousens S, Marchant T, Mshinda H, Schellenberg D, Tanner M, Schellenberg J.

PLoS Med. 2015 Sep 29;12(9):e1001881. doi: 10.1371/journal.pmed.1001881. eCollection 2015 Sep.

3.

Assessment of parental perception of malaria vaccine in Tanzania.

Romore I, Ali AM, Semali I, Mshinda H, Tanner M, Abdulla S.

Malar J. 2015 Sep 17;14:355. doi: 10.1186/s12936-015-0889-7.

4.

Setting research priorities across science, technology, and health sectors: the Tanzania experience.

de Haan S, Kingamkono R, Tindamanyire N, Mshinda H, Makandi H, Tibazarwa F, Kubata B, Montorzi G.

Health Res Policy Syst. 2015 Mar 12;13:14. doi: 10.1186/s12961-015-0002-2.

5.

Effect of home-based counselling on newborn care practices in southern Tanzania one year after implementation: a cluster-randomised controlled trial.

Penfold S, Manzi F, Mkumbo E, Temu S, Jaribu J, Shamba DD, Mshinda H, Cousens S, Marchant T, Tanner M, Schellenberg D, Schellenberg JA.

BMC Pediatr. 2014 Jul 22;14:187. doi: 10.1186/1471-2431-14-187.

6.

Institutional evolution of a community-based programme for malaria control through larval source management in Dar es Salaam, United Republic of Tanzania.

Chaki PP, Kannady K, Mtasiwa D, Tanner M, Mshinda H, Kelly AH, Killeen GF.

Malar J. 2014 Jun 25;13:245. doi: 10.1186/1475-2875-13-245.

7.

Child mortality patterns in rural Tanzania: an observational study on the impact of malaria control interventions.

Alba S, Nathan R, Schulze A, Mshinda H, Lengeler C.

Int J Epidemiol. 2014 Feb;43(1):204-15. doi: 10.1093/ije/dyt231. Epub 2013 Dec 19.

8.

Health system support for childbirth care in Southern Tanzania: results from a health facility census.

Hanson C, Ronsmans C, Penfold S, Maokola W, Manzi F, Jaribu J, Mbaruku G, Mshinda H, Tanner M, Schellenberg J.

BMC Res Notes. 2013 Oct 30;6:435. doi: 10.1186/1756-0500-6-435.

9.

Timeliness and completeness of vaccination and risk factors for low and late vaccine uptake in young children living in rural southern Tanzania.

Le Polain de Waroux O, Schellenberg JR, Manzi F, Mrisho M, Shirima K, Mshinda H, Alonso P, Tanner M, Schellenberg DM.

Int Health. 2013 Jun;5(2):139-47. doi: 10.1093/inthealth/iht006.

PMID:
24030114
10.

Clean home-delivery in rural Southern Tanzania: barriers, influencers, and facilitators.

Shamba DD, Schellenberg J, Penfold SC, Mashasi I, Mrisho M, Manzi F, Marchant T, Tanner M, Mshinda H, Schellenberg D, Hill Z.

J Health Popul Nutr. 2013 Mar;31(1):110-7.

11.

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic region.

Abdulla S, Salim N, Machera F, Kamata R, Juma O, Shomari M, Kubhoja S, Mohammed A, Mwangoka G, Aebi T, Mshinda H, Schellenberg D, Carter T, Villafana T, Dubois MC, Leach A, Lievens M, Vekemans J, Cohen J, Ballou WR, Tanner M.

Malar J. 2013 Jan 8;12:11. doi: 10.1186/1475-2875-12-11.

12.

A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern Tanzania.

Pearce RJ, Ord R, Kaur H, Lupala C, Schellenberg J, Shirima K, Manzi F, Alonso P, Tanner M, Mshinda H, Roper C, Schellenberg D.

J Infect Dis. 2013 Mar 1;207(5):848-59. doi: 10.1093/infdis/jis742. Epub 2012 Dec 5.

13.

Acceptability--a neglected dimension of access to health care: findings from a study on childhood convulsions in rural Tanzania.

Dillip A, Alba S, Mshana C, Hetzel MW, Lengeler C, Mayumana I, Schulze A, Mshinda H, Weiss MG, Obrist B.

BMC Health Serv Res. 2012 May 9;12:113. doi: 10.1186/1472-6963-12-113.

14.

Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study.

Khatib RA, Skarbinski J, Njau JD, Goodman CA, Elling BF, Kahigwa E, Roberts JM, MacArthur JR, Gutman JR, Kabanywanyi AM, Smith EE, Somi MF, Lyimo T, Mwita A, Genton B, Tanner M, Mills A, Mshinda H, Bloland PB, Abdulla SM, Kachur SP.

Malar J. 2012 Apr 30;11:140. doi: 10.1186/1475-2875-11-140.

15.

Neonatal deaths in rural southern Tanzania: care-seeking and causes of death.

Mrisho M, Schellenberg D, Manzi F, Tanner M, Mshinda H, Shirima K, Msambichaka B, Abdulla S, Schellenberg JA.

ISRN Pediatr. 2012;2012:953401. doi: 10.5402/2012/953401. Epub 2012 Jan 24.

16.

Human resources for health care delivery in Tanzania: a multifaceted problem.

Manzi F, Schellenberg JA, Hutton G, Wyss K, Mbuya C, Shirima K, Mshinda H, Tanner M, Schellenberg D.

Hum Resour Health. 2012 Feb 22;10:3. doi: 10.1186/1478-4491-10-3.

17.

Media, health workers, and policy makers' relationship and their impact on antimalarial policy adoption: a population genetics perspective.

Malisa A, Pearce R, Mutayoba B, Abdullah S, Mshinda H, Kachur P, Bloland P, Roper C.

Malar Res Treat. 2011;2011:217276. doi: 10.4061/2011/217276. Epub 2011 Jun 20.

18.

Cluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: evaluation of impact on survival.

Schellenberg JR, Maokola W, Shirima K, Manzi F, Mrisho M, Mushi A, Alonso P, Mshinda H, Tanner M, Schellenberg DM.

Malar J. 2011 Dec 30;10:387. doi: 10.1186/1475-2875-10-387.

19.

The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination.

Malisa AL, Pearce RJ, Mutayoba BM, Abdullah S, Mshinda H, Kachur PS, Bloland P, Roper C.

Malar J. 2011 Oct 26;10:317. doi: 10.1186/1475-2875-10-317.

20.

The case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle income countries.

Kapiriri L, Lavery JV, Singer PA, Mshinda H, Babiuk L, Daar AS.

BMC Public Health. 2011 Oct 18;11:811. doi: 10.1186/1471-2458-11-811.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk